Renal replacement therapy in special situations: Heart failure and neurological injury

Seminars in Dialysis

Volumn 24, Issue 2, 2011, Pages 192-196

  Mathew, Roy O ^a   Cerdá, Jorge ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOOP DIURETIC AGENT;

ACUTE KIDNEY FAILURE; ARTICLE; CHRONIC KIDNEY FAILURE; COMORBIDITY; HEART FAILURE; HEMODIAFILTRATION; HEMOFILTRATION; HUMAN; METHODOLOGY; NERVOUS SYSTEM INJURY; PERITONEAL DIALYSIS; SYNDROME; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; COMORBIDITY; HEART FAILURE; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SYNDROME; TRAUMA, NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 79955093717     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.00872.x     Document Type: Article

References (44)

1. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 52:1527-1539, 2008
2. Sarraf M, Masoumi A, Schrier RW: Cardiorenal syndrome in acute decompensated heart failure. Clin J Am Soc Nephrol 4:2013-2026, 2009
3. Cody RJ: Management of refractory congestive heart failure. Am J Cardiol 69:141G-147G, 1992; disc 147G-149G
4. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589-596, 2009
5. Shlipak M, Massie B: The clinical challenge of cardiorenal syndrome. Circulation 110:1514-1517, 2004
6. Vallon V: Tubuloglomerular feedback and the control of glomerular filtration rate. News Physiol Sci 18:169-174, 2003
7. Vallon V, Miracle C, Thomson S: Adenosine and kidney function: potential implications in patients with heart failure. Eur J Heart Fail 10:176-187, 2008
8. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT: BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105:1348-1353, 2002
9. Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, Liittschwager EB: Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 35:56-59, 2000
10. Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P: Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38:963-968, 2001
11. Evidence, W.G.T.R.N., Update the Guideline for the Management of Patients With Chronic Heart Failure Writing on Behalf of the Heart Failure Writing Committee, Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the international society for Heart and Lung Transplantation. Circulation 119:1977-2016, 2009
12. Bart BA, Boyle A, Bank AJ, Anand I, Olivari MT, Kraemer M, Mackedanz S, Sobotka PA, Schollmeyer M, Goldsmith SR: Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 46:2043-2046, 2005
13. Jaski BE, Ha J, Denys B, Lamba S, Trupp R, Abraham WT: Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 9:227-231, 2003
14. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka PA: Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 46:2047-2051, 2005
15. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA, for the UNLOAD Trial Investigators: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49:675-683, 2007
16. Costanzo MR, Saltzberg MT, Jessup M, Teerlink JR, Sobotka PA: Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail 16:277-284, 2010
17. Libetta C, Sepe V, Zucchi M, Pisacco P, Cosmai L, Meloni F, Campana C, Rampino T, Monti C, Tavazzi L, Dal Canton A: Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines. Nephrol Dial Transplant 22:2013-2019, 2007
18. Cnossen N, Kooman J, Konings C, van Dantzig J-M, van der Sande F, Leunissen K: Pertoneal dialysis in patients with congestive heart. Nephrol Dial Transplant 21(Suppl 2):63-66, 2006
19. Sanchez J, Ortega T, Rodriguez C, Diaz-Molina B, Martin M, Garcia-Cueto C, Vidau P, Gago E, Ortega F: Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 25:605-610, 2010
20. Nakayama M, Nakano H, Nakayama M: Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental pertoneal dialysis. J Cardiol 55:49-54, 2010
21. Uchino S, Kellum J, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney E, Tolwani A, Ronco C: Acute renal failure in critically ill patients: a multinational, multicenter study. J Am Med Assoc 294:813-818, 2005
22. Mehta R, Pascual M, Soroko S, Savage B, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM: Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int 66:1613-1621, 2004
23. Zygun D, Berthiaume L, Laupland K, Kortbeek J, Doig C: SOFA is superior to MOD score for the determination of non-neurologic organ dysfunction in patients with severe traumatic brain injury: a cohort study. Crit Care 10:R115, 2006
24. Zacharia BE, Ducruet AF, Hicman ZL, Grobelny BT, Fernandez L, Scmidt JM, Narula R, Ko LN, Cohen ME, Mayer SA, Connolly ES: Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid hemorrhage: a single-center cohort study. Stroke 40:2375-2381, 2009
25. Davenport A: Practical guidance for dialyzing a hemodialysis patient following acute brain injury. Hemodial Int 12:307-312, 2008
26. Sood P, Sinson GP, Cohen EP: Subdural hematomas in chronic dialysis patients: significant and increasing. Clin J Am Soc Nephrol 2:956-959, 2007
27. Foundation, B.T., A.A.o.N. Surgeons, C.o.N. Surgeons, and A.C.J.S.o.N.a.C. Care: Guidelines for the management of severe traumatic brain injury. J Neurotrauma 24(Suppl 1):S1, 2007
28. Narotam P, Morrison J, Nathoo N: Brain tissue oxygen monitoring in traumatic brain injury and major trauma: outcome analysis of a brain tissue oxygen-directed therapy. J Neurosurg 111:672-682, 2009
29. Ramakrishna R, Stiefel M, Udoteuk J, Spiotta A, Levine J, Kofke W, Zager E, Yang W, LeRoux P: Brain oxygen tension and outcome in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 109:1075-1082, 2008
30. Zhen-wei Z, Zhi-gang W: Acute cerebral and pulmonary edema induced by hemodialysis in a dog model. Chin Med J 121:1003-1009, 2008
31. Arieff A, Massry S, Barrientos A, Kleeman C: Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int 4:177-187, 1973
32. Silver S, Sterns R, Halperin M: Brain swelling after dialysis: old urea or new osmoles? Am J Kidney Dis 28:1-13, 1996
33. Krane NK: Intracranial pressure measurement in a patient undergoing hemodialysis and peritoneal dialysis. Am J Kidney Dis XIII:336-339, 1989
34. Davenport A, Will E, Davison A: Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int 43(Suppl 41):S245-S251, 1993
35. Caruso DM, Vishteh AG, Greene KA, Matthews MR, Carrion CA: Continuous hemodialysis for the management of acute renal failure in the presence of cerebellar hemorrhage. J Neurosurg 89:649-652, 1998
36. Davenport A: Continuous renal replacement therapies in patients with acute neurological injury. Semin Dial 22:165-168, 2009
37. Bagshaw S, Peets A, Hameed M, Boiteau PJ, Laupland KB, Doig C: Dialsyis Disequilibrium Syndrome: brain death following hemodialysis for metabolic acidosis and acute renal failure - a case report. BMC Nephrol 5:9, 2004
38. Oddo M, Levine J, Frangos S, Carrera E, Maloney-Wilensky E, Pascual JL, Kofke W, Mayer SA, LeRoux PD: Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry 80:916-920, 2009
39. Ivarsen P, Povlsen JV, Jensen JD: Increasing fill volume reduces cardiac performance in peritoneal dialysis. Nephrol Dial Transplant 22:2999-3004, 2007
40. van de Wetering J, Westendorp RGJ, van der Hoeven JG, Stolk B, Feuth JDM, Chang PC: Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 7:145-150, 1996
41. Oudemans-van Straaten HM, Wester JPJ, de Pont ACJM, Schetz M: Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 32:188-202, 2006
42. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991-1997, 1999
43. Kutsogiannis DJ, Mayers I, Chin WDNC, Gibney RTN: Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 35:802-811, 2000
44. Cerda J, Ronco C: Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial 22:114-122, 2009